EXPRES2ION BIOTECH HOLDING AB

Insiders ExpreS2ion Biotech Holding AB

Equities

EXPRS2

SE0008348262

Market Closed - Nasdaq Stockholm Other stock markets 11:29:31 2024-05-20 EDT			5-day change	1st Jan Change
1.364 ^SEK	-3.12%		-7.21%	-35.36%

05-16	ExpreS2ion Biotech Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-16	ExpreS2ion Announces Completion of GLP Safety Study for ES2B-C001 (HER2-VLP) Breast Cancer Vaccine Candidate	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ExpreS2ion Biotech Holding AB Announces Changes to Leadership Team	23-09-27	CI
ExpreS2ion Biotech Names Chief Scientific Officer	23-01-03	MT
ExpreS2ion Biotech Holding AB Appoints Dr. Farshad Guirakhoo as Chief Scientific Officer, Effective January 16, 2023	23-01-03	CI
ExpreS2ion Biotech Holding AB Announces Resignation of Allan Rosetzsky from the Board of Directors	22-10-06	CI
ExpreS2ion Biotech Holding AB Appoints Mattis F. Ranthe as New Chief Medical Officer, Effective February 1, 2022	21-12-21	CI
ExpreS2ion Biotech Holding AB Announces Board Changes	21-05-26	CI
ExpreS2ion Biotech Holding AB Announces Resignation of Gitte L. Pedersen from the Board of Directors	21-04-26	CI
ExpreS2ion Biotech Holding AB Announces Management Changes	21-01-11	CI
Expres2ion Biotech Holding AB Appoints Keith Alexander as New Chief Financial Officer, Effective October 1, 2020	20-08-18	CI
ExpreS2ion Biotechnologies Announces Change in Chief Executive Officer	19-12-20	CI
ExpreS2ion Biotech Holding AB Re-Appoints Mazars Set Revisionsbyrå AB as Auditor	19-05-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW